发明授权
- 专利标题： Radioimmunoconjugates for targeted alpha therapy
- 专利标题（中）： 用于靶向α治疗的放射免疫缀合物
-
申请号： US10567813申请日： 2004-07-29
-
公开(公告)号： US07632927B2公开(公告)日： 2009-12-15
- 发明人: Barry Allen , Syed Rizvi , Yong Li , Chang Fa On
- 申请人： Barry Allen , Syed Rizvi , Yong Li , Chang Fa On
- 申请人地址： BE
- 专利权人： The European Community, as Represented by the European Commision
- 当前专利权人： The European Community, as Represented by the European Commision
- 当前专利权人地址： BE
- 代理机构： Cantor Colburn LLP
- 优先权： AU2003904201 20030811
- 国际申请： PCT/EP2004/051663 WO 20040729
- 国际公布： WO2005/014052 WO 20050217
- 主分类号： C07K17/00
- IPC分类号： C07K17/00
摘要：
A radioimmunoconjugate for targeted alpha therapy comprises an alpha-emitter (e.g. Bi-213) linked to the monoclonal antibody C595. This radioimmunoconjugate is widely applicable in cancer therapy and is particularly efficient for treatment of pancreatic and prostate cancer, as well as for breast and ovarian cancer.
公开/授权文献
- US20070160529A1 Radioimmunoconjugates for targeted alpha therapy 公开/授权日：2007-07-12
信息查询
